In a 58-year-old man with hypertension, hypothyroidism, and benign prostatic hyperplasia who presents with headaches, back pain, frontal bossing, and skull X-ray showing thickened calvaria with mixed osteoblastic and osteolytic lesions, which serum findings are most likely (e.g., markedly elevated alkaline phosphatase with normal calcium and phosphate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Paget's Disease of Bone: Markedly Elevated Alkaline Phosphatase with Normal Calcium and Phosphate

This patient's clinical presentation—headaches, back pain, frontal bossing ("hat no longer fits"), and skull X-ray showing thickened calvaria with mixed osteoblastic and osteolytic lesions—is classic for Paget's disease of bone, which characteristically presents with markedly elevated alkaline phosphatase (ALP) while calcium and phosphate remain normal.

Expected Serum Findings

The most likely laboratory pattern in this patient is:

  • Alkaline phosphatase: Markedly elevated (often 2-10 times the upper limit of normal)
  • Calcium: Normal (8.6-10.4 mg/dL)
  • Phosphate: Normal (2.7-4.6 mg/dL)
  • Parathyroid hormone (PTH): Normal

Diagnostic Reasoning

Why Paget's Disease?

The clinical triad is pathognomonic 1:

  1. Progressive skull enlargement (frontal bossing, hat size increase)
  2. Bone pain (headaches, back pain)
  3. Radiographic findings showing thickened calvaria with mixed osteoblastic/osteolytic lesions

Why This Laboratory Pattern?

Alkaline phosphatase elevation reflects the intense osteoblastic activity characteristic of Paget's disease 1. The bone formation markers are dramatically elevated due to the accelerated bone turnover, yet this process does not disturb calcium-phosphate homeostasis because:

  • The bone remodeling is localized, not systemic
  • Intestinal calcium absorption remains normal
  • Renal handling of calcium and phosphate is preserved
  • PTH regulation remains intact

Key Differentials to Exclude

Primary Hyperparathyroidism

Would show:

  • Elevated calcium (>10.4 mg/dL, often >11 mg/dL)
  • Elevated PTH (>54 pg/mL)
  • Low or low-normal phosphate
  • Elevated ALP (but typically less dramatic than Paget's)

The normal calcium and PTH in this patient effectively rules out primary hyperparathyroidism 2, 3.

Secondary Hyperparathyroidism (CKD)

Would show:

  • Elevated PTH (often >10× upper limit)
  • Elevated phosphate (>4.6 mg/dL in CKD Stage 3-4)
  • Low or normal calcium
  • Elevated ALP

The normal phosphate and absence of renal dysfunction excludes this diagnosis 4.

Metastatic Bone Disease

Would typically show:

  • Elevated calcium (hypercalcemia of malignancy)
  • Variable ALP (elevated but pattern differs)
  • Multiple systemic symptoms
  • Different radiographic pattern (purely lytic or blastic, not mixed in same bone)

The localized skull involvement with characteristic mixed pattern and normal calcium argues against metastatic disease 5, 6.

Diagnostic Confirmation

After identifying the characteristic laboratory pattern, the Endocrine Society guidelines recommend 1:

  1. Plain radiographs of symptomatic areas (already done—shows thickened calvaria)
  2. Radionuclide bone scan to determine disease extent and identify asymptomatic sites
  3. Serum total alkaline phosphatase as the primary biochemical marker (or bone-specific ALP in adults for greater specificity)

Clinical Pitfalls to Avoid

Do not mistake Paget's disease for malignancy. The mixed osteoblastic-osteolytic pattern on skull X-ray can mimic metastatic disease, but the normal calcium with markedly elevated ALP is the key distinguishing feature 1, 7.

Do not overlook complications. With skull involvement, assess for:

  • Hearing loss (temporal bone involvement)
  • Cranial nerve compression
  • High-output cardiac failure (if extensive disease)
  • Pathologic fractures in weight-bearing bones

Do not delay treatment. The patient has symptomatic disease (headaches, back pain) with radiographic evidence of active disease, meeting criteria for bisphosphonate therapy 1.

Related Questions

What is the appropriate management for a 31‑year‑old bedridden woman with serum calcium 7.1 mg/dL, albumin 4.2 g/dL, alkaline phosphatase 3528 U/L, and 25‑hydroxy‑vitamin D 9 ng/mL?
In an elderly female with a low globulin level (1.8 g/dL) and otherwise normal CBC, total protein, albumin, albumin/globulin ratio, bilirubin, alkaline phosphatase, AST, ALT, and intact parathyroid hormone, what additional tests are indicated to evaluate the low globulin?
What are the possible causes of a lytic skull lesion in an adult?
Can I write a case report about this 64‑year‑old female nurse with primary hyperparathyroidism, hypothyroidism, adrenal incidentaloma, osteoporosis managed with alendronate, ibandronate, denosumab, and romosozumab who developed an atypical subtrochanteric femur fracture, and is such a report worth publishing?
How do I calculate the corrected calcium and what is the appropriate management for a patient with serum calcium 6.9 mg/dL, albumin 5.0 g/dL, and phosphorus 7.5 mg/dL?
What analgesic options are safe for a patient with long QT syndrome?
What is the recommended acute management for a patient with T‑cell acute lymphoblastic leukemia presenting with acute pulmonary involvement?
What diagnosis should be documented for a patient with residual atrophy of the left lower extremity due to prior poliomyelitis?
Can iron deficiency anemia cause moderate splenomegaly?
What are the possible diagnoses for a 58-year-old man with hypertension, hypothyroidism, and benign prostatic hyperplasia who presents with headaches, back pain, a hat that no longer fits, thickened calvarium, and mixed osteoblastic/osteolytic skull lesions?
Which test should be performed to evaluate testosterone levels?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.